US Broker Ratings

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 29% Revenue Growth

Oscar Health, Inc. (NYSE: OSCR), a notable player in the healthcare plan sector, currently trades at $19.39, reflecting a marginal dip of 0.08% in its recent price change. While its..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 25.67% Upside Amidst Strong Revenue Growth

TG Therapeutics, Inc. (TGTX), a prominent player in the biotechnology sector, is making waves with its focus on innovative treatments for B-cell mediated diseases. With a market capitalization of $5.5..

Alcon Inc. (ALC) Stock Analysis: Healthcare Titan Offers 27% Upside Potential

As a cornerstone of the medical instruments and supplies industry, Alcon Inc. (NYSE: ALC) stands as a formidable player in the global eye care market. With a market capitalization of..

Waters Corporation (WAT) Stock Analysis: A Promising 5.92% Potential Upside for Healthcare Investors

Waters Corporation (NYSE: WAT), a significant player in the healthcare sector, particularly within the diagnostics and research industry, presents an intriguing opportunity for investors. With a market capitalization of $19.92..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Innovator with a 49.67% Upside Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands at the forefront of the healthcare sector, specializing in diagnostic and therapeutic products that aid clinicians in diagnosing and treating a variety of diseases,..

Biogen Inc. (BIIB) Stock Analysis: A 20.52% Potential Upside Amidst Robust Product Line

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, is capturing investor attention with its promising potential upside of 20.52%. As a leading figure in the drug manufacturing industry,..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Powerhouse with a 71.88% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, is drawing investor attention with its impressive market cap of $8.29 billion and a promising pipeline of treatments..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Analyst Consensus Indicates Strong “Buy” with Significant Growth Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a Boston-based biopharmaceutical company, is capturing the attention of investors with its promising focus on treating rare neuroendocrine diseases. With a market capitalization of $7.32..

AstraZeneca PLC (AZN) Stock Analysis: Navigating Growth with a 6% Upside Potential

AstraZeneca PLC (AZN), a titan in the healthcare sector, continues to make significant strides in the pharmaceutical industry. Headquartered in Cambridge, UK, AstraZeneca is a key player in the discovery,..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 26% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the global healthcare sector, is drawing investor attention with its significant potential upside of 26.27%. As a Spanish-based plasma therapeutic company, Grifols..

Teleflex Incorporated (TFX) Stock Analysis: A Healthcare Giant with Modest Growth Potential

Teleflex Incorporated (NYSE: TFX) is a notable player in the medical instruments and supplies industry, offering a wide range of single-use medical devices that cater to critical care and surgical..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: A 37.91% Upside Potential Amidst Robust Buy Ratings

Jazz Pharmaceuticals plc (JAZZ), a prominent player in the biotechnology sector, has captured investor attention with its promising potential upside of 37.91%, as indicated by recent analyst ratings. Headquartered in..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unpacking a 29% Upside Potential in Biotech Innovation

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, has been capturing investor attention with its innovative approach to treating debilitating diseases through muscle activators and inhibitors. Headquartered..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Insight on Its 8.62% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $20.19 billion, this U.S.-based..

Legend Biotech Corporation (LEGN) Stock Analysis: Significant Upside Potential with an Average Target Price of $75.06

Legend Biotech Corporation (NASDAQ: LEGN) is a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $5.9 billion, the company is headquartered in..

Chemed Corp (CHE) Stock Analysis: Unlocking a 31% Upside Potential

Chemed Corp (NYSE: CHE) is a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $6.42 billion, Chemed is a formidable..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unveiling a Potential 55% Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology industry, is making waves with its innovative approach to biopharmaceutical solutions. With a market capitalization of $15.59 billion, this..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: 60% Potential Upside Amidst Healthcare Innovations

Inspire Medical Systems, Inc. (NASDAQ: INSP), a leader in medical devices focusing on obstructive sleep apnea (OSA), is capturing investor attention with a significant potential upside of 60.41%. As a..

Danaher Corporation (DHR) Stock Analysis: Exploring a 16.5% Potential Upside for Investors

Investors looking to diversify their portfolio with a strong player in the healthcare sector might find Danaher Corporation (NYSE: DHR) an intriguing option. Known for its extensive reach in diagnostics..

Philips (PHG) Stock Analysis: Navigating a 16.85% Upside Amidst Healthcare Innovations

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the healthcare sector, continues to capture the attention of investors with its diverse portfolio in the medical devices industry. Headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds